Stock GPFT GRAPEFRUIT USA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Grapefruit USA, Inc.

Equities

GPFT

US3885981049

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets
Other stock markets
 12:57:48 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.0014 USD 0.00% Intraday chart for Grapefruit USA, Inc. +16.67% +7.69%
2022 Grapefruit USA, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
2022 Hall of Fame Wrestler and Cannabis Pioneer Rob Van Dam to Launch RVD Cannabis Brand in California Through Licensing Deal with Grapefruit USA, Inc CI

Valuation

Fiscal Period: December 2019 2020 2021
Capitalization 1 35.74 42.88 10.59
Enterprise Value (EV) 1 38.65 47.62 16.21
P/E ratio -2.23 x -8.5 x -1.78 x
Yield - - -
Capitalization / Revenue 79.2 x 11.7 x 18 x
EV / Revenue 85.7 x 13 x 27.5 x
EV / EBITDA -21.3 x -42.4 x -11.6 x
EV / FCF 20,271,024 x -14,331,716 x -101,372,982 x
FCF Yield 0% -0% -0%
Price to Book -8.06 x -9.19 x -1.82 x
Nbr of stocks (in thousands) 486,320 504,450 557,163
Reference price 2 0.0735 0.0850 0.0190
Announcement Date 4/10/20 4/20/21 4/15/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021
Net sales 1 0.1815 0.4512 3.672 0.589
EBITDA 1 -0.2436 -1.812 -1.123 -1.399
EBIT 1 -0.2683 -1.876 -1.206 -2.416
Operating Margin -147.83% -415.86% -32.85% -410.14%
Earnings before Tax (EBT) 1 -0.3665 -4.6 -4.057 -5.505
Net income 1 -0.3665 -4.609 -4.057 -5.505
Net margin -201.93% -1,021.51% -110.47% -934.65%
EPS 2 -0.0400 -0.0329 -0.0100 -0.0107
Free Cash Flow - 1.906 -3.323 -0.1599
FCF margin - 422.54% -90.48% -27.15%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 4/10/20 4/10/20 4/20/21 4/15/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021
Net Debt 1 1.2 2.9 4.74 5.62
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) -4.909 x -1.601 x -4.222 x -4.017 x
Free Cash Flow - 1.91 -3.32 -0.16
ROE (net income / shareholders' equity) - 218% 89% 105%
ROA (Net income/ Total Assets) - -50.3% -26% -51.5%
Assets 1 - 9.167 15.58 10.69
Book Value Per Share 2 0.0100 -0.0100 -0.0100 -0.0100
Cash Flow per Share 2 0 0 0 0
Capex - - - -
Capex / Sales - - - -
Announcement Date 4/10/20 4/10/20 4/20/21 4/15/22
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
GRAPEFRUIT USA, INC. Stock Grapefruit USA, Inc.
+7.69% 1.55M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. GPFT Stock
  4. Financials Grapefruit USA, Inc.